Cargando…

Adherence and persistence with branded antidepressants and generic SSRIs among managed care patients with major depressive disorder

OBJECTIVE: This study compared adherence and persistence of three branded antidepressants: the serotonin and norepinephrine reuptake inhibitors (SNRIs) duloxetine and venlafaxine XR, and the selective serotonin reuptake inhibitor (SSRI) escitalopram; and generic selective SSRIs, and examined demogra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xianchen, Chen, Yi, Faries, Douglas E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169979/ https://www.ncbi.nlm.nih.gov/pubmed/21935334 http://dx.doi.org/10.2147/CEOR.S17846

Ejemplares similares

Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data
por: Solem, Caitlyn T, et al.
Publicado: (2016)

The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries
por: Fugger, Gernot, et al.
Publicado: (2022)

Antidepressants: From MAOIs to SSRIs and more
por: Ramachandraih, Chaitra T., et al.
Publicado: (2011)

Resveratrol supplementation enhanced SSRIs efficacy in premenopausal women with major depressive disorder
por: Fedotova, J., et al.
Publicado: (2023)

Serotonin reuptake inhibitor antidepressants (SSRIs) against atherosclerosis
por: Wozniak, Greta, et al.
Publicado: (2011)

Brand-Name Antidepressants Outperform Their Generic Counterparts in Preventing Hospitalization for Depression: The Real-World Evidence from Taiwan
por: Hsu, Chih-Wei, et al.
Publicado: (2020)

Usefulness of LDAEP to Predict Tolerability to SSRIs in Major Depressive Disorder: A Case Report
por: Park, Young-Min, et al.
Publicado: (2012)

Effect of SSRIs on Resting-State Functional Brain Networks in Adolescents with Major Depressive Disorder
por: Chu, Shu-Hsien, et al.
Publicado: (2021)

Medication Adherence and Persistence in Patients with Severe Major Depressive Disorder with Psychotic Features: Antidepressant and Second-Generation Antipsychotic Therapy Versus Antidepressant Monotherapy
por: Kim-Romo, Dawn N., et al.
Publicado: (2016)

Serotonin transporter occupancy with TCAs and SSRIs: a PET study in patients with major depressive disorder
por: Lundberg, Johan, et al.
Publicado: (2012)

Adherence to, and Persistence of, Antidepressant Therapy in Patients with Major Depressive Disorder: Results from a Population-based Study in Italy
por: Di Nicola, Marco, et al.
Publicado: (2023)

Brand and generic medications: Are they interchangeable?
por: Al-Jazairi, Abdulrazaq S., et al.
Publicado: (2008)

Prescription writing: Generic or brand?
por: Andrade, Chittaranjan, et al.
Publicado: (2017)

Brand Name Versus Generic?
por: Aungaroon, Gewalin
Publicado: (2023)

A MRS study of metabolic alterations in the frontal white matter of major depressive disorder patients with the treatment of SSRIs
por: Zhang, Yifan, et al.
Publicado: (2015)

Predictors of duloxetine adherence and persistence in patients with fibromyalgia
por: Cui, Zhanglin, et al.
Publicado: (2012)

Barriers and facilitators of adherence to antidepressants among outpatients with major depressive disorder: A qualitative study
por: Ho, Siew Ching, et al.
Publicado: (2017)

The influence of antidepressant and psychotherapy treatment adherence on future work leaves for patients with major depressive disorder
por: Gaspar, Fraser W., et al.
Publicado: (2020)

Adherence and Persistence Across Antidepressant Therapeutic Classes: A Retrospective Claims Analysis Among Insured US Patients with Major Depressive Disorder (MDD)
por: Keyloun, Katelyn R., et al.
Publicado: (2017)

Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study
por: Desai, Rishi J, et al.
Publicado: (2018)

Should antidepressants be used for major depressive disorder?
por: Jakobsen, Janus Christian, et al.
Publicado: (2020)

Resting-State fMRI in Predicting Response to Treatment With SSRIs in First-Episode, Drug-Naive Patients With Major Depressive Disorder
por: Zhang, Aixia, et al.
Publicado: (2022)

Discontinuation Rates and Health Care Costs in Adult Patients Starting Generic Versus Brand SSRI or SNRI Antidepressants in Commercial Health Plans
por: Kautzner, Adam, et al.
Publicado: (2011)

Effects of serotonin in the hippocampus: how SSRIs and multimodal antidepressants might regulate pyramidal cell function
por: Dale, Elena, et al.
Publicado: (2015)

Data on the impact of SSRIs and depression symptoms on the neural activities in obsessive–compulsive disorder at rest
por: Chen, Yunhui, et al.
Publicado: (2016)

Association between increased serum interleukin-8 levels and improved cognition in major depressive patients with SSRIs
por: Cai, Yuan, et al.
Publicado: (2023)

The effect of knowledge and expectations on adherence to and persistence with antidepressants
por: Woodward, Sophie Claire, et al.
Publicado: (2016)

TED—trazodone effectiveness in depression: a naturalistic study of the effeciveness of trazodone in extended release formulation compared to SSRIs in patients with a major depressive disorder
por: Dudek, Dominika, et al.
Publicado: (2023)

Adherence to antidepressant therapy for major depressive patients in a psychiatric hospital in Thailand
por: Prukkanone, Benjamas, et al.
Publicado: (2010)

Repeated use of SSRIs potentially associated with an increase on serum CK and CK-MB in patients with major depressive disorder: a retrospective study
por: Wu, Shengwei, et al.
Publicado: (2021)

P.0403 Disticnt effects of SSRIs therapy in patients with the first episode of major depressive disorder/generalized anxiety disorder after COVID-19 disease
por: Bereza, Z., et al.
Publicado: (2021)

Safety and efficacy of generic drugs with respect to brand formulation
por: Gallelli, Luca, et al.
Publicado: (2013)

Evaluation of Physical Properties of Generic and Branded Travoprost Formulations
por: Wadhwani, Meenakshi, et al.
Publicado: (2016)

Placental serotonin: implications for the developmental effects of SSRIs and maternal depression
por: Velasquez, Juan C., et al.
Publicado: (2013)

Addressing adherence to antidepressant treatment for depression
por: Mayes, Taryn L., et al.
Publicado: (2020)

Comparative efficacy of generic nifedipine versus brand‐name amlodipine for hypertension management in Taiwan
por: Lee, Hao‐Wei, et al.
Publicado: (2022)

ARPNet: Antidepressant Response Prediction Network for Major Depressive Disorder
por: Chang, Buru, et al.
Publicado: (2019)

Pharmacogenetics of SSRIs and Sexual Dysfunction
por: Osis, Liana, et al.
Publicado: (2010)

Cyclosporine: A Commentary on Brand versus Generic Formulation Exchange
por: Singh, A. K., et al.
Publicado: (2011)

A critical review of brand and generic alendronate for the treatment of osteoporosis
por: Brown, Jacques P, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4g6oake0g4k82gmu9bvbm9t5ap